Zentalis Pharmaceuticals
Clinical-stage biopharmaceutical company focused on developing clinically differentiated, novel small molecule therapeutics. Learn more
Launch date
Employees
Market cap
€209m
Enterprise valuation
€213m (Public information from Sep 2024)
Share price
$4.22 ZNTL
New York City New York (HQ)
Authorizing premium user...